440 results on '"Jiang, Yi‐Zhou"'
Search Results
2. Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
3. Myeloid-derived suppressor cells-induced exhaustion of CD8 + T-cell participates in rejection after liver transplantation
4. Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection
5. Advances in targeting histone deacetylase for treatment of solid tumors
6. Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy
7. Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
8. DNAzyme-based faithful probing and pulldown to identify candidate biomarkers of low abundance
9. Molecular classification of hormone receptor-positive HER2-negative breast cancer
10. Radiomics in breast cancer: Current advances and future directions
11. Vitamin drinks improve palatability and reduce adverse events associated to polyethylene glycol electrolyte solutions
12. Targeting transposable elements in cancer: developments and opportunities
13. Deep learning framework for comprehensive molecular and prognostic stratifications of triple-negative breast cancer
14. Genetic interactions reveal distinct biological and therapeutic implications in breast cancer
15. Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities
16. Single-cell morphological and topological atlas reveals the ecosystem diversity of human breast cancer
17. Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer
18. SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches
19. Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial
20. Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
21. Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria
22. Emerging therapies in cancer metabolism
23. A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer
24. CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancer
25. Modeling of novel RF AlGaN/GaN HEMTs with the structure of n-Si drain extension
26. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
27. The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target
28. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
29. Clinical evidence of outcomes following liver transplantation in patients with nonalcoholic steatohepatitis: An updated meta-analysis and systematic review
30. Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
31. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
32. Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer
33. Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis
34. A comprehensive genomic and transcriptomic dataset of triple-negative breast cancers
35. Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
36. Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial
37. Domino hepatocyte transplantation using explanted human livers with metabolic defects attenuates D-GalN/LPS-induced acute liver failure
38. N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis
39. Integration of radiogenomic features for early prediction of pathological complete response in patients with triple-negative breast cancer and identification of potential therapeutic targets
40. Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens
41. SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1‐Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC.
42. Correction: Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells.
43. Early transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a systematic review and meta-analysis
44. ASO Visual Abstract: A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer
45. ASO Author Reflections: Deeper Insight into Therapeutic Implications and Non-invasive Detection of Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Results from a Multi-omics Cohort Study
46. 333.10: The Role of Immunosuppression Level in Liver Allograft Fibrosis After Pediatric Liver Transplantation
47. 211.13: No Difference in Posttransplant Survival Among Patients With or Without Nonalcoholic Steatohepatitis: A Meta-analysis and Meta-regression
48. Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor
49. Triple-negative breast cancer: new treatment strategies in the era of precision medicine
50. Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.